Effect of Dapagliflozin on Renal Oxygen Delivery and Consumption in T2DM and NGT Subjects

被引：0
|
作者：
Tripathy, Devjit
Chen, Xi
Chilton, Robert
Hansis-Diarte, Andrea A.
Salehi, Marzieh
Solis-Herrera, Carolina
Cersosimo, Eugenio
Defronzo, Ralph A.
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-869-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
869-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Mitochondrial reactive oxygen species generation in obese non-diabetic and T2DM subjects
    Abdul-Ghani, M.
    Jani, R.
    Chaves, A.
    Molina, M.
    Tripathy, D.
    DeFronzo, R.
    DIABETOLOGIA, 2008, 51 : S250 - S251
  • [32] Predicting renal function decline in patients with T2DM
    George Jerums
    Richard J. MacIsaac
    Nature Reviews Endocrinology, 2014, 10 : 381 - 382
  • [33] Predicting renal function decline in patients with T2DM
    Jerums, George
    MacIsaac, Richard J.
    NATURE REVIEWS ENDOCRINOLOGY, 2014, 10 (07) : 381 - 382
  • [34] Mechanisms of exenatide attenuation of postprandial hyperglycaemia in T2DM subjects
    Cersosimo, E.
    DIABETOLOGIA, 2007, 50 : S111 - S111
  • [35] Safety and Efficacy of Dapagliflozin in Patients with T2DM and Cardiovascular Disease Receiving Loop Diuretics
    Cefalu, William T.
    Leiter, Lawrence
    Johnsson, Eva
    Sugg, Jennifer
    Gause-Nilsson, Ingrid
    DIABETES, 2015, 64 : A314 - A314
  • [36] DAPAGLIFLOZIN PHARMACOKINETICS IS SIMILAR BETWEEN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION WITH/WITHOUT T2DM AND T2DM PATIENTS WITHOUT HEART FAILURE.
    Melin, J.
    Parkinson, J.
    Hamren, B.
    Penland, R.
    Boulton, D.
    McMurray, J.
    Tang, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S71 - S71
  • [37] Long-Term Safety and Efficacy of Dapagliflozin in Patients with T2DM and Cardiovascular Disease
    Cefalu, William T.
    Leiter, Lawrence A.
    Johnsson, Eva
    Sugg, Jennifer
    Gause-Nilsson, Ingrid
    DIABETES, 2015, 64 : A28 - A29
  • [38] Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients
    Al Jobori, Hussein
    Daniele, Giuseppe
    Adams, John
    Cersosimo, Eugenio
    Triplitt, Curtis
    DeFronzo, Ralph A.
    Abdul-Ghani, Muhammad
    DIABETES OBESITY & METABOLISM, 2017, 19 (06): : 809 - 813
  • [39] Aortic Pulse Wave Velocity Is an Independent Predictor of Renal Function Decline and Stroke in T2DM Subjects
    Fountoulakis, Nikos
    Smith, Andrew
    Viberti, Giancarlo
    Gnudi, Luigi
    Karalliedde, Janaka
    DIABETES, 2015, 64 : A117 - A117
  • [40] Patterns of Acylcarnitines in Offsprings of T2DM Patients Compare to Control Subjects
    Lavalle-Gonzalez, Fernando J.
    Villarreal-Perez, Jesus Z.
    Mancillas-Adame, Leonardo G.
    Gonzalez-Gonzalez, Jose G.
    Navarrete-Acosta, Francisco A.
    Aguirre-Rodriguez, Ana A.
    Garza-Romero, Aaron C.
    Martinez-De Villarreal, Laura F.
    DIABETES, 2009, 58 : A604 - A604
12345